Monica A. Slavin
Elite in Febrile Neutropenia

Monica A. Slavin

305 Grattan Street, 
Melbourne, VIC, AU 
Elite in Febrile Neutropenia
305 Grattan Street, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Monica Slavin practices in Melbourne, Australia. Ms. Slavin is rated as an Elite expert by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Febrile Neutropenia, Agranulocytosis, Infantile Neutropenia, Bone Marrow Transplant, and Lung Transplant.

Her clinical research consists of co-authoring 366 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 17 articles and participated in 1 clinical trial in the study of Febrile Neutropenia.

Gender
Female

Locations

305 Grattan Street, Melbourne, VIC 3000, Australia
Other Locations
300 Grattan Street, Parkville, VIC 3050, Australia
St Andrews Place, East Melbourne, VIC 3002, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Enrollment Status: Completed
Publish Date: July 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.
COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.
Enrollment Status: Completed
Publish Date: August 24, 2023
Intervention Type: Drug
Study Drugs: IFN-Alpha, Selinexor, Lenzilumab
Study Phase: Phase 3
Early Diagnosis and Treatment of Infections in Patients With Haematologic Malignancies: Examining Novel Diagnostics Including Bacterial and Fungal Multiplex PCR and FDG-PET Imaging
Early Diagnosis and Treatment of Infections in Patients With Haematologic Malignancies: Examining Novel Diagnostics Including Bacterial and Fungal Multiplex PCR and FDG-PET Imaging
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 2 Less Clinical Trials

366 Total Publications

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified-Release Posaconazole Prophylaxis.
The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified-Release Posaconazole Prophylaxis.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: September 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Slavin's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 43 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile